FIELD: medicine.
SUBSTANCE: patient's skin condition is diagnosed by assessing the effectiveness of fibroblast colony-formation, as a parameter describing regeneration cell potential and percentage of dense and diffuse colonies in a cell culture as parameters describing proliferative cell potential. The effectiveness of colony-formation is calculated as percentage ratio of the formed colonies of cell count more than 20 to total explanted cell count. In the other version, a proliferation parameter describing proliferative cell potential is calculated by formula: PP=[1(DC)+2(MC)+3(DenseC)]/100(%), wherein PP is the proliferation parameter; DC is percentage of diffuse colonies, (%); MC is percentage of mixed colonies, (%); DenseC is percentage of dense colonies, (%).
EFFECT: application of the given group of inventions enables diagnosing the condition of fibroblast population of patient's skin.
4 cl, 6 dwg, 6 ex, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
BIOTRANSPLANT AND METHOD FOR CORRECTION OF SOFT TISSUE DEFECT, METHOD FOR PREPARING BIOTRANSPLANT | 2005 |
|
RU2281776C1 |
SKIN EQUIVALENT AND METHOD FOR ITS PRODUCTION | 2006 |
|
RU2342164C2 |
METHOD OF TREATING NEUROTPOPHIC ULCERS OF EXTREMITIES | 2010 |
|
RU2446811C2 |
BIOTRANSPLANT, METHOD FOR ITS OBTAINING (VARIANTS) AND METHOD FOR TREATING DILATION CARDIOMYOPATHY | 2004 |
|
RU2268062C1 |
EPITHELIAL CELL CULTIVATION ADDITIVE | 2019 |
|
RU2711920C1 |
BIOTRANSPLANT FOR TREATMENT OF DEGENERATIVE AND TRAUMATIC DISEASE OF CARTILAGE TISSUE AND METHOD FOR ITS PREPARING | 2005 |
|
RU2301677C1 |
COMPOSITION FOR CELL-REPLACEMENT THERAPY OF SOFT TISSUE DEFECTS | 2013 |
|
RU2522816C1 |
BIOTRANSPLANT AND METHOD FOR TREATING THE CASES OF OSTEOPOROSIS | 2004 |
|
RU2265442C1 |
METHOD OF NEOGENESIS PROCESSES CORRECTION | 2007 |
|
RU2350340C1 |
BISAMIDE DERIVATIVE OF DICARBOXYLIC ACID AS AGENT FOR STIMULATING TISSUE REGENERATION AND RECOVERY OF DIMINISHED TISSUE FUNCTION | 2015 |
|
RU2647438C2 |
Authors
Dates
2012-11-20—Published
2011-10-03—Filed